News
In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to ...
The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...
The U.S. CDC recommends RSV vaccines for high-risk adults aged 50-59, endorsing the views of the former vaccine advisory ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results